saxenda glp 1 agonist First Generic GLP-1 Injection OK'd for Weight Loss Saxenda (Liraglutide) | Lifestyle Medical
Description
83% of patients saw significant improvement in their diseases compared to 18% on placebo
PubMed 96
58 For all phase 2a, AEs were mild-moderate and GI-related, with no SAEs related to GSBR-1290
With the increasing use of GLP-1 medications for the treatment of type 2 diabetes and obesity, understanding regarding their impact on other medications that require gastric absorption is limited
Adding a significant dose of fiber on top of that adaptation process is a recipe for discomfort
[DOI] [PMC free article] [PubMed] [Google Scholar] 69
